Events

Field Safety Notices about Symbiq One-Channel and Two-Channel Infusers

According to Health Products Regulatory Authority, this field safety notices involved a device in Ireland that was produced by Hospira.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Event Country
    Ireland
  • Event Source
    HPRA
  • Event Source URL
    http://www.hpra.ie/docs/default-source/Safety-Notices/fsnsummary_oct2010_qmsversion_final_061110-(2).pdf?sfvrsn=0
  • Notes / Alerts
    Irish data is current through April 2019. All of the data comes from the Health Products Regulatory Authority (Ireland), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Ireland.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
    Advice has been provided by the manufacturer regarding the use of the device. 3rd Party Publications

Device

Symbiq One-Channel and Two-Channel Infusers
  • Model / Serial
  • Product Description
    Symbiq One-Channel and Two-Channel Infusers
  • Manufacturer
    Hospira

Manufacturer

Hospira
  • Manufacturer Parent Company (2017)
    Pfizer
  • Source
    HPRA